TY  - GEN
AU  - Schaefer,Martin
AU  - Hinzpeter,Axel
AU  - Mohmand,Ariane
AU  - Janssen,Gesa
AU  - Pich,Maurice
AU  - Schwaiger,Markus
AU  - Sarkar,Rahul
AU  - Friebe,Astrid
AU  - Heinz,Andreas
AU  - Kluschke,Michael
AU  - Ziemer,Marlene
AU  - Gutsche,Juri
AU  - Weich,Viola
AU  - Halangk,Juliane
AU  - Berg,Thomas
TI  - Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects
SN  - 0270-9139
PY  - 2007///1130
KW  - Adult
KW  - Antidepressive Agents
KW  - therapeutic use
KW  - Antiviral Agents
KW  - adverse effects
KW  - Depression
KW  - chemically induced
KW  - Drug Therapy, Combination
KW  - Female
KW  - Genotype
KW  - Hepatitis C, Chronic
KW  - drug therapy
KW  - Humans
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Logistic Models
KW  - Male
KW  - Mental Disorders
KW  - complications
KW  - Middle Aged
KW  - Polyethylene Glycols
KW  - Prospective Studies
KW  - Recombinant Proteins
KW  - Ribavirin
KW  - Risk Factors
KW  - Substance-Related Disorders
KW  - Treatment Outcome
N1  - Publication Type: Controlled Clinical Trial; Journal Article
UR  - https://doi.org/10.1002/hep.21791
ER  -